These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22934787)

  • 1. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus.
    Patel CG; Ogasawara K; Akhlaghi F
    Xenobiotica; 2013 Mar; 43(3):229-35. PubMed ID: 22934787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.
    El-Sheikh AA; Koenderink JB; Wouterse AC; van den Broek PH; Verweij VG; Masereeuw R; Russel FG
    Transl Res; 2014 Jul; 164(1):46-56. PubMed ID: 24486136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus".
    Picard N
    Xenobiotica; 2013 Sep; 43(9):836-8. PubMed ID: 23339626
    [No Abstract]   [Full Text] [Related]  

  • 4. MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood.
    Berthier J; Benmameri M; Sauvage FL; Fabre G; Chantemargue B; Arnion H; Marquet P; Trouillas P; Picard N; Saint-Marcoux F
    Xenobiotica; 2021 Jan; 51(1):105-114. PubMed ID: 32820679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.
    Kobayashi M; Saitoh H; Kobayashi M; Tadano K; Takahashi Y; Hirano T
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1029-35. PubMed ID: 14978191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
    Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
    Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
    Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
    Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
    Naesens M; Kuypers DR; Streit F; Armstrong VW; Oellerich M; Verbeke K; Vanrenterghem Y
    Clin Pharmacol Ther; 2006 Nov; 80(5):509-21. PubMed ID: 17112807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.
    Hesselink DA; van Hest RM; Mathot RA; Bonthuis F; Weimar W; de Bruin RW; van Gelder T
    Am J Transplant; 2005 May; 5(5):987-94. PubMed ID: 15816878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.
    Matsunaga N; Suzuki K; Nakanishi T; Ogawa M; Imawaka H; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):142-8. PubMed ID: 25989889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
    Matsunaga N; Wada S; Nakanishi T; Ikenaga M; Ogawa M; Tamai I
    Mol Pharm; 2014 Feb; 11(2):568-79. PubMed ID: 24320552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
    Djebli N; Picard N; Rérolle JP; Le Meur Y; Marquet P
    Pharmacogenet Genomics; 2007 May; 17(5):321-30. PubMed ID: 17429314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.
    Braun F; Schöcklmann H; Ziegler E; Kunzendorf U; Armstrong VW; Renders L
    Clin Pharmacol Ther; 2009 Oct; 86(4):411-5. PubMed ID: 19606088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
    Takekuma Y; Kakiuchi H; Yamazaki K; Miyauchi S; Kikukawa T; Kamo N; Ganapathy V; Sugawara M
    J Pharm Pharm Sci; 2007; 10(1):71-85. PubMed ID: 17498396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.
    Fahrmayr C; König J; Auge D; Mieth M; Münch K; Segrestaa J; Pfeifer T; Treiber A; Fromm M
    Br J Pharmacol; 2013 May; 169(1):21-33. PubMed ID: 23387445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
    J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats.
    Kwon MH; Yoon JN; Baek YJ; Kim YC; Cho YY; Kang HE
    Biopharm Drug Dispos; 2016 Sep; 37(6):352-65. PubMed ID: 27241939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
    Patel CG; Harmon M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.